Gyre Therapeutics, Inc. revenue breakdown overview

Gyre Therapeutics, Inc. revenue for the last year amounted to 113.45 M USD, the most of which — 794.00 k USD — came from its highest performing source at the moment, Protease Engineering, the year earlier bringing 7.34 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Gyre Therapeutics, Inc. 794.00 k USD, and the year before that — 7.34 M USD.